Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the new US stance could change the TRIPS waiver debate.
The CureVac mRNA vaccine is currently in final stages of clinical trials - but it is expected to perform like Pfizer and Moderna, with the bonus of surviving at ordinary refrigeration temperatures.
Researchers studied over 30,688 HIV patients across seven Latin American countries - finding that life expectancy has dramatically increased over a period of 14 years.
Researchers at Harvard University found that Black women are four times more likely to die of COVID than white men - the data also revealed that Black women are three times more likely to die of the virus than Asian men.
US authorities paused the use of the Johnson & Johnson single dose vaccine as they look into six cases of blood clots that developed in women aged between 18 and 48.
Indiana University of Medicine researchers spent four years developing a blood test to identify depression and bipolar disorder - they say this work will bring psychiatry from "the 19th century into the 21st".
Scientists have developed an implantable sensor using gold nanoparticles, which can function in the human body for "several months" to report health changes.
A "human error" created a factory mixup for Johnson & Johnson in Baltimore, Maryland, damaging up to 15 million vaccine doses - but this does not impact doses that are ready for use.
Real-world use of the Moderna and Pfizer vaccines in the United States reveals that both are working at 90% efficacy - with data pointing to one dose being capable of 80% protection.
Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
According to new ONS data, 36% of UK people who are vaccine hesitant have strong side effect fears - while a further 12% fear needles, and 22% think vaccines could impact fertility.
Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.
